Literature DB >> 626555

Management of alcohol withdrawal syndromes.

W L Thompson.   

Abstract

Withdrawal from alcohol (ethanol, ethyl alcohol) or other general sedatives leads to progressive hyperactivity that progresses from tremulousness, sleep disturbance, and hallucinosis, to the more serious rum fits and delirium tremens (DTs). Withdrawal can be prevented and, in most cases, arrested by prompt replacement of alcohol with paraldehyde, benzodiazepines or other general sedatives. Diazepam is appropriate replacement therapy for most patients. When delirium is manifest, the chance is greater than 15% that the patient will die, and this reaction cannot be aborted. The patient with DTs must be calmed with a general sedative that has a rapid onset of maximal effect to prevent overdosage. Diazepam, 5 mg intravenously every five minutes, permits evaluation of the maximal effect of each dose before the next dose is administered. Although some patients have advance sedative or alcohol withdrawal, great care must be taken to elicit the proper history of alcohol abuse so that sedative replacement therapy will prevent or abort early withdrawal, thus sparing the patient a mortality equivalent to that of acute myocardial infarction or Russian roulette.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 626555

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  9 in total

1.  Current approaches to the recognition and treatment of alcohol withdrawal and delirium tremens: "old wine in new bottles" or "new wine in old bottles".

Authors:  Theodore A Stern; Anne F Gross; Thomas W Stern; Shamim H Nejad; Jose R Maldonado
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 2.  The drug management of severe alcohol withdrawal syndrome.

Authors:  M A Gillman; F J Lichtigfeld
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 3.  Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment.

Authors:  R C Turner; P R Lichstein; J G Peden; J T Busher; L E Waivers
Journal:  J Gen Intern Med       Date:  1989 Sep-Oct       Impact factor: 5.128

Review 4.  Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management.

Authors:  H P Landolt; J C Gillin
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.

Authors:  J S Duncan; S D Shorvon; M R Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

6.  Non-convulsive status epilepticus after abrupt withdrawal of hypnotic-sedative drugs.

Authors:  M Emre; H Walser; G Baumgartner
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

Review 7.  Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal.

Authors:  Steven J Weintraub
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

8.  Correlation between the epigenetic modification of histone H3K9 acetylation of NR2B gene promoter in rat hippocampus and ethanol withdrawal syndrome.

Authors:  Duan Li; Yanqing Zhang; Yanting Zhang; Qi Wang; Qin Miao; Yahui Xu; Jair C Soares; Xiangyang Zhang; Ruiling Zhang
Journal:  Mol Biol Rep       Date:  2019-03-22       Impact factor: 2.316

9.  Risk factors for delirium tremens development.

Authors:  J A Ferguson; C J Suelzer; G J Eckert; X H Zhou; R S Dittus
Journal:  J Gen Intern Med       Date:  1996-07       Impact factor: 5.128

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.